A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data.

ABSTRACT:

Introduction

Thrombotic complications of coronavirus disease 2019 (COVID-19) have received considerable attention. Although numerous conflicting findings have compared escalated thromboprophylaxis doses with a standard dose to prevent thrombosis, there is a paucity of literature comparing clinical outcomes in three different anticoagulation dosing regimens. Thus, we investigated the effectiveness and safety profiles of standard, intermediate, and high-anti-coagulation dosing strategies in COVID-19 critically ill patients.

Methodology

This retrospective multicenter cohort study of intensive care unit (ICU) patients from the period of April 2020 to August 2021 in four Saudi Arabian centers. Inclusion criteria were age ≥ 18 years, diagnosis with severe or critical COVID-19 infe

SUBMITTER: Alrashed A 

PROVIDER: S-EPMC9424612 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature